RAIDS atlas of significant genetic and protein biomarkers in cervical cancer

J Gynecol Oncol. 2023 Sep;34(5):e74. doi: 10.3802/jgo.2023.34.e74.

Abstract

Loss of function in epigenetic acting genes together with driver alterations in the PIK3CA pathway have been shown significantly associated with poor outcome in cervical squamous cell cancer. More recently, a CoxBoost analysis identified 16 gene alterations and 30 high level activated proteins to be of high interest, due to their association with either good or bad outcome, in the context of treatment received by chemoradiation. The objectives here were to review and confirm the significance of these molecular alterations as suggested by literature reports and to pinpoint alternate treatments options for poor-responders to chemoradiation.

Keywords: Chemoradiation; Post Translational Protein Modifications; Targeted Treatments; Treatment Combinations; BioRAIDs; Genetic & Proteomic Biomarkers.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Breast Neoplasms*
  • Carcinoma, Squamous Cell* / genetics
  • Carcinoma, Squamous Cell* / therapy
  • Chemoradiotherapy
  • Female
  • Humans
  • Uterine Cervical Neoplasms* / genetics
  • Uterine Cervical Neoplasms* / therapy

Substances

  • Biomarkers